Literature DB >> 6105889

Requirement of thiols for activation of coronary arterial guanylate cyclase by glyceryl trinitrate and sodium nitrite: possible involvement of S-nitrosothiols.

L J Ignarro, C A Gruetter.   

Abstract

Glyceryl trinitrate specifically required cysteine, whereas NaNO2 at concentrations less than 10 mM required one of several thiols or ascorbate, to activate soluble guanylate cyclase from bovine coronary artery. However, guanylate cyclase activation by nitroprusside or nitric oxide did not require the addition of thiols or ascorbate. Whereas various thiols enhanced activation by nitroprusside, none of the thiols tested enhanced activation by nitric oxide. S-Nitrosocysteine, which is formed when cysteine reacts with either NO-2 or nitric oxide, was a potent activator of guanylate cyclase. Similarly, micromolar concentrations of the S-nitroso derivatives of penicillamine, GSH and dithiothreitol, prepared by reacting the thiol with nitric oxide, activated guanylate cyclase. Guanylate cyclase activation by S-nitrosothiols resembled that by nitric oxide and nitroprusside in that activation was inhibited by methemoglobin, ferricyanide and methylene blue. Similarly, guanylate cyclase activation by glyceryl trinitrae plus cysteine, and by NaNO2 plus either a thiol or ascorbate, was inhibited by methemoglobin, ferricyanide and methylene blue. These data suggest that the activation of guanylate cyclase by each of the compounds tested may occur through a common mechanism, perhaps involving nitric oxide. Moreover, these findings suggest that S-nitrosothiols could act as intermediates in the activation of guanylate cyclase by glyceryl trinitrate, NaNO2 and possibly nitroprusside.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105889     DOI: 10.1016/0304-4165(80)90297-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  67 in total

1.  Influence of redox compounds on nitrovasodilator-induced relaxations of rat coronary arteries.

Authors:  M E Murphy
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 2.  Routes for formation of S-nitrosothiols in blood.

Authors:  Enika Nagababu; Joseph M Rifkind
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

Review 3.  Nitrates and nitrites in the treatment of ischemic cardiac disease.

Authors:  Vaughn E Nossaman; Bobby D Nossaman; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Jul-Aug       Impact factor: 2.644

Review 4.  After 130 years, the molecular mechanism of action of nitroglycerin is revealed.

Authors:  Louis J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

5.  Synthesis, characterization and crystal structure of a dinuclear iron nitrosyl complex with 2-mercapto-1-[2-(4-pyridyl)-ethyl]-benzimidazolyl.

Authors:  Rongming Wang; Wei Xu; Jian Zhang; Lijuan Li
Journal:  J Mol Struct       Date:  2009-04-17       Impact factor: 3.196

Review 6.  Mechanisms of action of nitrates.

Authors:  K E Torfgård; J Ahlner
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

7.  N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

Review 8.  Endothelium-derived nitric oxide: pharmacology and relationship to the actions of organic nitrate esters.

Authors:  L J Ignarro
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

9.  Non-adrenergic, non-cholinergic relaxation of the bovine retractor penis muscle: role of S-nitrosothiols.

Authors:  X Liu; J S Gillespie; W Martin
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

Review 10.  Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion.

Authors:  R M Egdell; T Siminiak; D J Sheridan
Journal:  Basic Res Cardiol       Date:  1994 Nov-Dec       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.